Compare VIR & ROCK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VIR | ROCK |
|---|---|---|
| Founded | 2016 | 1972 |
| Country | United States | United States |
| Employees | N/A | 2221 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.4B |
| IPO Year | 2019 | 1996 |
| Metric | VIR | ROCK |
|---|---|---|
| Price | $10.92 | $44.19 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $19.43 | N/A |
| AVG Volume (30 Days) | ★ 1.9M | 200.3K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 17.49 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $68,556,000.00 | ★ $1,135,501,000.00 |
| Revenue This Year | $270.22 | $41.26 |
| Revenue Next Year | N/A | $20.14 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.75 | $33.56 |
| 52 Week High | $11.94 | $75.08 |
| Indicator | VIR | ROCK |
|---|---|---|
| Relative Strength Index (RSI) | 51.55 | 46.19 |
| Support Level | $8.43 | $42.51 |
| Resistance Level | $10.67 | $46.02 |
| Average True Range (ATR) | 0.53 | 1.79 |
| MACD | -0.11 | -0.15 |
| Stochastic Oscillator | 16.19 | 43.78 |
Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.
Gibraltar Industries Inc manufactures and provides products and services for the Renewable energy, Residential, Agtech, and Infrastructure markets. The Renewable Segment is engaged in designing, engineering, manufacturing, and installing solar racking and electrical balance systems. Agtech Segment provides growing and processing solutions including the designing, engineering, manufacturing, full-scope construction, maintenance, and support of greenhouses and indoor growing operations, and botanical extraction systems. It derives key revenue from the Residential segment which offers roof and foundation ventilation products, single point and centralized mail systems electronic package solutions, and Retractable awnings and gutter guards, among other products.